Docetaxel (DT) in anthracycline-pretreated advanced breast cancer (ABC): Toxicity and activity

被引：0
|
作者：
Ferraresi, V [1 ]
Vaccaro, A [1 ]
Milella, M [1 ]
D'Ottavio, AM [1 ]
Papaldo, P [1 ]
Nistico, C [1 ]
Thorel, MF [1 ]
Marsella, A [1 ]
Terzoli, E [1 ]
Cognetti, F [1 ]
机构：
[1] Regina Elena Canc Inst, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
88P
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [21] Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
    N Batista
    G Perez-Manga
    M Constenla
    A Ruiz
    F Carabantes
    J Castellanos
    M Gonzalez Barón
    K Villman
    M Söderberg
    J Ahlgren
    J Casinello
    P Regueiro
    A Murias
    British Journal of Cancer, 2004, 90 : 1740 - 1746
  • [22] Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer
    Lortholary, A
    Delozier, T
    Monnier, A
    Bourgeois, H
    Bougnoux, P
    Tubiana-Mathieu, N
    Riffaud, JC
    Besson, D
    Lotz, V
    Gamelin, E
    BRITISH JOURNAL OF CANCER, 2003, 88 (11) : 1669 - 1674
  • [23] Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer
    A Lortholary
    T Delozier
    A Monnier
    H Bourgeois
    P Bougnoux
    N Tubiana-Mathieu
    J Ch Riffaud
    D Besson
    V Lotz
    E Gamelin
    British Journal of Cancer, 2003, 88 : 1669 - 1674
  • [24] Evaluation of fulvestrant (F) activity and toxicity in heavily pretreated patients with advanced breast cancer (ABC)
    Catania, C.
    Ascione, G.
    Medici, M.
    Verri, E.
    Sanna, G.
    Marenghi, C.
    Minchella, I.
    Adamoli, L.
    Goldhirsch, A.
    Nole, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 126 - 126
  • [25] Phase III study of gemcitabine plus docetaxel versus capecitabine plus docetaxel for anthracycline-pretreated metastatic breast cancer patients: survival results
    Chan, S.
    Romieu, G.
    Huober, J.
    Tubiana-Hulin, M.
    Schneeweiss, A.
    Lluch, A.
    Llombart, A.
    du Bois, A.
    Carrasco, E.
    Thareau, Vaury A.
    Fumoleau, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S68 - S68
  • [26] Gemcitabine plus docetaxel versus capecitabine plus docetaxel for patients with anthracycline-pretreated metastatic breast cancer: a review of the results of a European Phase III trial
    Chan, S
    EJC SUPPLEMENTS, 2005, 3 (05): : 17 - 21
  • [27] A phase III trial of Gemcitabine plus Docetaxel (GD) versus Capecitabine plus Docetaxel (CD) for patients (pt) with anthracycline-pretreated metastatic breast cancer
    Chan, S.
    Sharma, R.
    Romieu, G.
    Huober, T.
    Delozier, T.
    Tubiana-Hulin, M.
    Schneeweiss, A.
    Lluch, A.
    Llombart, A.
    du Bois, A.
    Carrasco, E.
    Thareau, A.
    Fumoleau, P.
    EJC SUPPLEMENTS, 2007, 5 (03): : 15 - 16
  • [28] MITOMYCIN-C AND MITOXANTRONE IN ANTHRACYCLINE-PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY
    PERRONE, F
    DEPLACIDO, S
    CARLOMAGNO, C
    GRAVINA, A
    DELAURENTIIS, M
    DELMASTRO, L
    GRIDELLI, C
    PAGLIARULO, C
    BIANCO, AR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (03): : 218 - 222
  • [29] Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma:: a retrospective study
    Autier, J
    Picard-Dahan, C
    Marinho, E
    Grossin, M
    Yeni, P
    Leport, C
    Vildé, JL
    Crickx, B
    Descamps, V
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (05) : 1026 - 1029
  • [30] Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer
    C Kosmas
    N Tsavaris
    N Malamos
    N Stavroyianni
    A Gregoriou
    S Rokana
    A Polyzos
    British Journal of Cancer, 2003, 88 : 1168 - 1174
12345